All solvents and reagents, including cucurbit [6]uril hydrate (CB6·XH 2 O), and β-cyclodextrin hydrate (βCD·XH 2 O), were purchased from commercial suppliers and used without further purification. N-propargylglycine, S1 and PyAA + S2 were prepared according to literature procedures. Thin layer chromatography (TLC) was performed on silica gel 60 F 254 (E. Merck) and visualized under a UV lamp at 254 nm. Column chromatography was carried out on silica gel 60 (E. Merck, 230-400 mesh). A C-18 column was used for analytical and semi-preparative reverse phase high performance liquid chromatography (RP-HPLC) on an Agilent 1100 Series Capillary LC. Runs were eluted with H 2 O/MeCN (0.1 % v/v TFA) and monitored using a UV-Vis detector. Nuclear magnetic resonance (NMR) spectra were recorded on Bruker Avance 600 or 500 with working frequencies of 600, or 500 MHz, respectively. Data for 1 H NMR spectra are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz), and integration. Chemical shifts are referenced to the residual non-deuterated solvents for 1 H (CDCl 3 : δ = 7.27 ppm, CD 3 CN: δ = 1.94 ppm, (CD 3 ) 2 SO: δ = 2.50 ppm) and 13 C (CDCl 3 : δ = 77.0 ppm, CD 3 CN: δ = 118.26 ppm, (CD 3 ) 2 SO: δ = 39.52 ppm) nuclei. Matrix assisted laser desorptionionization time-of-flight mass spectrometry (MALDI-TOF MS) was performed on a Voyager-DE system (PerSeptive Biosystems, USA) and data were analyzed using Data Explorer software. (1). Peptide 1 was synthesized using standard Fmoc solid phase peptide synthesis (SPPS) on Tentagel S-RAM resin (Rapp Polymere, Tuebingen, Germany). Side chain protecting groups used were Arg(pbf) and Lys(dde).
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Electronic N-propargylglycine-GGGG (S1) and N-propargylglycine-GPLG (S2) . Peptides S1 and S2 were synthesized using standard Fmoc solid phase peptide synthesis (SPPS) on Gly-Wang resin (Anaspec, Fremont, CA). Deprotection of the Fmoc groups was performed with two 10 min incubations in a 30% v/v piperidine in dimethylformamide (DMF) solution. Couplings were carried out using 10 equiv of amino acid with 10 equiv of 2-(6-chloro-1-H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU), and 20 equiv of N,Ndiisopropylethylamine (DIPEA) in DMF for 20 min. The N-terminus of the peptide was modified on resin with N-propargylglycine using the same coupling conditions. Peptides were cleaved from the resin after incubation with a solution of 95:2.5:2.5 TFA:TIPS:H 2 O for 2-3 h.
Excess TFA was removed under a stream of N 2 and the peptide was precipitated in cold diethyl ether. The precipitate was redissolved in H 2 O and purified by RP-HPLC, eluting in an aqueous gradient 5% to 95% MeCN/0.1% TFA in H 2 O/0.1% TFA over 45 min at a flow rate of 3.0 mL/min. After lyophilization, peptides were obtained as off-white powders (S1, 3.5 mg; S2, 3.8 mg 
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S4. Xenon hyperCEST NMR.
Xenon polarization was achieved using a home built spin-exchange optical-pumping setup resulting in a 10% polarization of a xenon gas mixture (2 % Xe, 10% N 2 , 88% He). S3 The hyperpolarized gas was bubbled directly into a 5 mm phantom containing the solution of interest for 20 s then left to settle for 2 s. The sample was held at 3.4 atm and 25 °C throughout. A 9.4 T (400 MHz) Varian VNMRS console was used for all hyperCEST experiments with optimized saturation power and duration for each sample. A standard hyperCEST pulse sequence was used sweeping the saturation frequency, at 20 dB, in 1000 Hz increments 7000 Hz to 29000 Hz, also including a measurement at 11250 and 11500 Hz where CB6 is typically observed, and at 19500
Hz, corresponding to the center of the 129 Xe@H 2 O peak covering a 200 ppm range in total. S4 The saturation pulse length was 4 s for three cycles at 20 dB. For % CEST effect data, an on/off saturation experiment was conducted saturating at the center of the CB6 peak then switching to 29000 Hz on the other side of the 129 Xe@H 2 O peak alternating 8 times for a total of 4 on saturation and 4 off saturation values. Data processing was carried out using MATLAB. FIDs were zero-filled to 16384 points, baseline was corrected, apodized with an 11 Hz exponential, S6 and a Fourier transform was performed. Each 129 Xe@H 2 O areas in the spectra were integrated and the contrast of each spectrum was compared between the maximum and minimum area in each data series. Each profile was fitted with Lorentz profile using ORIGINLAB. S5 The percent CEST effect is obtained by alternating the on and off resonance saturation frequencies and observing the integrated area of the dissolved xenon peak. For CB6 the on resonance saturation is around 11250 Hz so the off resonance saturation is placed equidistant on the other side of the water peak at 27750 Hz. The placement of the saturation peaks is such that if the saturation pulse for the on resonance peak has any overlap with the dissolved water peak, it will have the same overlap during the off resonance saturation. For this study the on/off cycle was repeated 4 times for each rotaxane and pseudorotaxane then the % CEST effect was determined bynormalizing the spectra and taking the signal from the on resonance and dividing it by the off resonance and subtracting from one, %CEST effect = (1 -S on /S off ), for each cycle. The signal for xenon-NMR experiments is generated external to the sample of interest. This causes fluctuations in the amount of polarized xenon dissolved in water for each scan. By taking 25 off resonance scans the fluctuation is signal due to xenon polarization and bubbling was determined to be +/-3.5% of the average Xe@H 2 O signal so a percent CEST effect must be greater than 7%
for it to be considered significant. For the locked rotaxane the percent CEST effect was determined to be less then 4% and thus can be concluded that no measurable CEST is taking place. Figure S1 . RP-HPLC chromatogram of purified rotaxane 2. At all wavelengths measured, only one major peak is observed. Figure S2 . COSY NMR spectrum of rotaxane 2. Figure S3 . MALDI-TOF MS of rotaxane 2 after hyperCEST. MS confirmed that rotaxane 2 remained intact after hyperCEST spectra were obtained. Figure S4 . 129 Xe hyperCEST spectra of free CB6 at 1000, 500, 100, and 10 nM inNaPhos pH 7.
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